title: Pulse perfusion value predicts eye opening after sevoflurane anaesthesia: an explorative study.
abstract: The variables measured in modern pulse oximetry apparatuses include a graphical pulse curve and a specified perfusion value (PV) that could be a sensitive marker for detecting differences in sympathetic activity. We hypothesized that there is a correlation between a reduction of PV and the time to eye opening after general anaesthesia. The objective was to investigate whether PV can predict eye opening after sevoflurane anaesthesia. Prospective, explorative clinical study included 20 patients, ASA physical status 1 or 2, at Skåne University Hospital, Lund, Sweden, from November 2012 to January 2013 scheduled for elective breast tumour surgery. A general anaesthesia was delivered with inhalation of oxygen, nitrous oxide and sevoflurane anaesthesia to a depth of 1.2 minimal alveolar concentration. Sevoflurane inspiratory and expiratory concentrations were measured. Bispectral index monitoring, PV as measured by pulse oximeter, heart rate and carbon dioxide were registered at before anaesthesia, 15 min after induction (at 1.2 minimal alveolar concentration), at end of surgery and at eye opening at the end of anaesthesia. PV values were lower before anaesthesia and at eye opening compared to at 15 min after induction and at end of surgery (P < 0.05). The reduction of PV between end of surgery and eye opening was 0.76. We conclude that the pulse oximeter PV could be a useful variable to assess the timing of recovery, in terms of eye opening after a general anaesthesia.
authors.affiliation: Section of Anaesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, bruno.enekvist@med.lu.se.
authors.forename: Bruno
authors.initials: B
authors.lastname: Enekvist
authors.forename: Anders
authors.initials: A
authors.lastname: Johansson
mesh_terms: D000368:Aged; D000758:Anesthesia / Q000379:methods*; D000762:Anesthesia Recovery Period; D000768:Anesthesia, General; D018685:Anesthetics, Inhalation / Q000627:therapeutic use; D001794:Blood Pressure; D001943:Breast Neoplasms / Q000601:surgery; D002245:Carbon Dioxide / Q000032:analysis; D056805:Consciousness Monitors; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008738:Methyl Ethers / Q000627:therapeutic use*; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D009609:Nitrous Oxide / Q000627:therapeutic use; D010092:Oximetry; D010100:Oxygen / Q000627:therapeutic use; D010477:Perfusion; D010991:Plethysmography; D011446:Prospective Studies; D000077149:Sevoflurane
chemical_list: D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D002245:Carbon Dioxide; D000077149:Sevoflurane; D009609:Nitrous Oxide; D010100:Oxygen